Skip to main navigation Skip to search Skip to main content

Sell v. U.S. Involuntary Medication to Restore Trial Competency - A Workable Standard?

Research output: Contribution to journalReview articlepeer-review

Abstract

Competency to Stand Trial (CST) evaluations are common in the U.S. criminal justice system. Of those defendants found Incompetent to Stand Trial (IST), psychotic disorders are the most common diagnoses, and active psychotic symptoms are strongly correlated with impairments in trial-related abilities. If a defendant is rendered IST because of psychosis, restoration will be unlikely without antipsychotic medication. Last term, in Sell v. U.S., the U.S. Supreme Court dealt with medication refusal in the context of competency restoration. The Court held that involuntary medication, under certain circumstances, is appropriate. This article includes a review of earlier relevant legal decisions and an analysis and discussion of the Sell decision.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalJournal of the American Academy of Psychiatry and the Law
Volume32
Issue number1
StatePublished - 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Sell v. U.S. Involuntary Medication to Restore Trial Competency - A Workable Standard?'. Together they form a unique fingerprint.

Cite this